Trust is the currency of relationships and a primary focus for public relations leaders in the biopharma industry. Earning brand trust is a challenge in any industry, but especially in a highly regulated industry with inherent risks. Although trust saw a slight bump during the COVID-19 pandemic, the pharmaceutical industry is still the least trusted sector of healthcare, according to the Edelman Trust Barometer. Increasing distrust driven by fake news, combined with the demand for corporate social advocacy, make understanding trust and participating in the conversation more essential today than ever.
This panel delves into the strategies for cultivating trust within the industry, based on recent research findings. The discussion will highlight proven methods for enhancing trust while aligning with your brand's overarching goals. Attendees will gain insights into refining messaging strategies, measuring impact effectively, and fostering enduring trust with stakeholders.
- Understand and apply the latest research on trust in pharma that will increase brand reputation and uptake with key attributes of trust.
- Address the state of trust in the pharma industry, current practices that are building trust for individual brands and for the industry as a whole, and expectations for pharma brands looking to the future.
- Connect research to practice with a discussion of practical approaches and examples of reputation building through key trust attributes.
- Proactively address disinformation and misinformation to maintain trust and safeguard reputation.
- Calibrate your communication on social issues to increase positive brand perception and connection, while avoiding backlash.
